Paper 69 - UPDATED EFFICACY, SAFETY, AND TREATMENT DISCONTINUATION OUTCOMES OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION SARCOMAS

Author(s)

• NF

  Noah Federman, MD

  UCLA David Geffen School of Medicine
  Los Angeles, California, United States

  Slides

Co-Author(s)

• SD

  Steven G. DuBois, MD, MS

  Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA
  Boston, Massachusetts, United States
• Cv

  Cornelis M. van Tilburg, MD, PhD

  Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ), Heidelberg, Germany
  Heidelberg, Baden-Wurttemberg, Germany
• DO

  Daniel Orbach, MD, PhD

  SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, and University PSL, Paris, France
  Paris, Ile-de-France, France
• CM

  Christian Michel Zwaan, MD, PhD

  Prinses Maxima Centrum, Utrecht, the Netherlands and Erasmus MC-Sophia Children’s Hospital, Rotterdam, Netherlands
  Utrecht, Utrecht, Netherlands
• CB

  Claudia Blattmann, MD

  Olgahospital, Stuttgart, Germany
  Stuttgart, Baden-Wurttemberg, Germany
• BG

  Birgit Geoerger, MD, PhD

  Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, INSERM U1015, Villejuif, France
  Villejuif, Ile-de-France, France
• CA

  Catherine M. Albert, MD

  Seattle Children’s Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
  Seattle, Washington, United States
• RN

  Ramamoorthy Nagasubramanian, MD

  Stanford Medicine Children’s Health, Palo Alto, CA, USA
  Palo Alto, California, United States
• TW

  Tanya Watt, MD

  University of Texas Southwestern Medical Center, Dallas, TX, USA
  Dallas, Texas, United States
• NN

  Natascha Neu, MSc

  Chrestos Concept GmbH & Co. KG, Essen, Germany
  Essen, Nordrhein-Westfalen, Germany
• 

  Esther De La Cuesta, MD, MBA

  Pediatric Advisor/ Senior Clinical Development Leader, Oncology
  Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA
  Whippany, New Jersey, United States
• VB

  Vadim Bernard-Gauthier, PhD

  Bayer Pharmaceuticals, Inc., Toronto, ON, Canada
  Toronto, Ontario, Canada
• LM

  Leo Mascarenhas, MD, MS

  Cedars-Sinai Medical Center, California, CA, USA
  California, California, United States
• 

  Theodore W. Laetsch, MD (he/him/his)

  Associate Professor
  The Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA
  Philadelphia, Pennsylvania, United States
• YZ

  Yizhuo Zhang, MD

  Sun Yat-sen University Cancer Center, Guangzhou, China
  Guangzhou, Guangdong, China (People's Republic)